(3-314) Optimizing the Potential of Zafirlukast as an Antithrombotic Agent Through the Creation of Second-generation Analogs

Monday, December 5, 2022

12:00 PM – 1:00 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Oncology/Hematology

Co-Author(s): Kaitlind Howard, Justine Gelzinis, Sylvie Garneau-Tsodikova, Daniel Kennedy

Primary Author(s)